-+ 0.00%
-+ 0.00%
-+ 0.00%

Medtronic Invests In Pi-Cardia To Accelerate Innovation For Complex Transcatheter Aortic Valve Replacement Patients And Procedures

Benzinga·09/01/2026 10:32:31
Listen to the news

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, and Pi-Cardia Ltd., a pioneer in leaflet modification technologies for structural heart disease, today announced a strategic investment by Medtronic in Pi-Cardia Ltd. With a focus on addressing the evolving needs of increasingly complex transcatheter aortic valve replacement (TAVR) patients and procedures, Medtronic secures an option for strengthening its structural heart portfolio through this strategic investment, supporting the next generation of innovation.